Big Pharma manages symptoms. This startup resolves the root cause.

For over 125 years, inflammation care has relied on symptom suppression.

Aspirin was groundbreaking in its time — but in a world plagued by chronic inflammation — we all need something better.

​Sen-Jam​ is pioneering the first true leapfrog advance in inflammatory care.

Q: What do cancer, heart disease, and rheumatoid arthritis have in common? A: Inflammation drives them all.

Inflammation is a silent epidemic, at the core of countless chronic diseases. Yet today’s treatments only mask symptoms or worse suppress the body’s immune system, leaving the root cause untouched.

Sen-Jam changes that.

With its revolutionary ​PAIR (Pleiotropic Anti-Inflammatory Remedies)​ technology, Sen-Jam comprehensively targets inflammation at its source, delivering the most transformative advance since aspirin was invented.

This isn’t just an improvement—it’s a paradigm shift.

How does Sen-Jam work?

Most therapies target single inflammatory pathways — like fighting a wildfire with a squirt gun 🔥🔫

PAIR acts like a maestro, coordinating multiple inflammatory pathways for additive, powerful results.

In a Phase 2 clinical trial for SJP-002C, PAIR demonstrated:

• Strong efficacy in treating respiratory inflammation

• An exceptional safety profile, addressing both symptoms and roo causes.

“Our approach is so simple and powerful, it’s like discovering the next aspirin — an essential solution that changes everything.

Why invest in Sen-Jam?

• Massive TAM: Inflammation underlies a wide range of diseases, driving a $125 billion market projected by 2030.

• Unprecedented Innovation: 60 patents strong, Sen-Jam’s groundbreaking platform is positioned to disrupt the $1.48T pharma industry.

• Past successful exits: Backed by a team of scientific experts and entrepreneurial veterans with a proven track record.

“This is the inflection point. Science, timing, and market demand have aligned for the biggest advance in 125 years.

Perks of investing

• Invest any amount and get ​Fractional Royalty Rights​ as annual dividends

• Bonus Incentives for Larger Investments:

  • $25k+: 10% bonus in stock

  • $50k+: 12% bonus in stock

  • $100k+: 14% bonus in stock

Note: these favorable terms sunset February 15th

Be part of the next breakthrough in healthcare.

Express interest

Click the button below to:

1. Gain access to exclusive updates

2. Take your place in shaping the future of healthcare

3. Invest in the most transformative advance in over a century

The future of inflammation care starts now.

Transform health. Transform lives. Transform your portfolio.

To learn more about Sen-Jam without giving permission to email, ​click here​.

📰 Market Headlines

Markets staged a dramatic recovery today after yesterday's AI-triggered selloff.

• The Dow gained over 0.3% and the S&P 500 climbed to 0.9%.

Consumer confidence deteriorated for the second straight month in January, dropping to 104.1 from December's 109.5.

The US Navy banned DeepSeek from all work and personal use, citing security concerns.

President Trump's new Treasury Secretary, Scott Bessent, won Senate confirmation in a 68-29 vote.

🎰 Alts this week

🚪 TrueCrowd shuts down

🎨 Sotheby’s art sales down 28%, new focus on Saudi Arabia

🍗 Popeyes announces ​collab with Don Julio​ tequila

💵 Rare bicentennial quarter hits $15 million valuation

⚾️ Ultimate Jewish baseball card collection up for auction

🧠 Make yourself heard

Goldman put a $3k price target on gold for 2025.

 📊 Ideas, trends, and analysis

• A Harvard study revealed consuming just 7 grams of olive oil daily reduced dementia-related death risk by 28%.

😱 Fear and Greed Index

📊 Winners and losers

Earnings, upgrades, and acquisitions

• Boeing reported its largest loss since 2020 at $11.83 billion from production issues and labor strikes; shares tumbled 2.15%.

• GM forecast 2025 earnings of $11-$12 per share, beating estimates, but shares slipped 1.65%.

• Starbucks beat revenue expectations at $9.4 billion despite a 4% same-store sales decline; shares fell 2.13%.

• Lockheed Martin shares dropped over 3% after Q4 sales missed estimates and shares dipped 3.38%.

• Royal Caribbean surged 4.4% after beating Q4 earnings estimates; shares reached 7.72%.

Market movers

• Workers at a Philadelphia Whole Foods voted to form Amazon's first union at the grocery chain.

• OpenAI launched ChatGPT Gov, a version of its chatbot specifically designed for federal agencies.

• Bookshop.org began an e-book platform to compete with Amazon's Kindle dominance.

• Legoland Florida announced 234 layoffs, with 75% coming from its entertainment department.

🎤 What you said last time

📺 What to Watch Today